Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Nextech3D.ai Announces First New Customer Win For its AI Powered Photography Studio (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
IMV Inc
IMVIF
Healthcare
Biotechnology
IMV Inc. is a Canada-based company. The Company has no business operations.
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (GREY:IMVIF)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(43)
•••
Breakthorough1
X
Post by
Breakthorough1
on Aug 09, 2023 6:51am
The debt
That's what they had to pay to Horizon: 2023: $47.000 2024: $15,302.000 2025: $9,749.000 Nothing for ACOA's debt. Why didn't they try to reach december (ASH meeting)?
(1)
•••
Jthom376
X
Comment by
Jthom376
on Aug 06, 2023 7:08am
RE:RE:RE:RE:I guess the SEC should know this
I anticipate a case will be made - and like VXRT, I expect we will end up with a letter in the mail from a law firm. But if they are bankrupt... is there anything left?
(43)
•••
Breakthorough1
X
Comment by
Breakthorough1
on Aug 05, 2023 2:35pm
RE:RE:RE:I guess the SEC should know this
This case stated that a statement can contain forward-looking and not forward-looking elements (as perhaps this case, but here the forward-looking statement relies on a historical fact, ie, they
...more
(43)
•••
Breakthorough1
X
Comment by
Breakthorough1
on Aug 05, 2023 2:20pm
RE:RE:I guess the SEC should know this
Combined with this. March 16th too: "We are targeting a full disclosure of the data in the third quarter. We have enough data in hand to be confident about the direction that, that’s pointing
...more
(43)
•••
Breakthorough1
X
Comment by
Breakthorough1
on Aug 05, 2023 2:02pm
RE:I guess the SEC should know this
Don't think it is covered by this. They said they had the money to the moment they could see data. March 16th too. "During this call, we will discuss our business outlook and make forward
...more
(43)
•••
Breakthorough1
X
Post by
Breakthorough1
on Aug 05, 2023 1:41pm
I guess the SEC should know this
March 16th: "In December, we raised $9 million, which brought our December 31 cash to $21.2 million. This cash takes us into the second half of 2023 and will allow us to see through
...more
(43)
•••
Breakthorough1
X
Post by
Breakthorough1
on Aug 05, 2023 12:43pm
And SEC link
https://www.sec.gov/tcr
(43)
•••
Breakthorough1
X
Post by
Breakthorough1
on Aug 05, 2023 10:17am
SEC/FDA and misleading statements about data
"The bad news: Failing to properly disclose material events regarding clinical trial data may result in more than harm to company’s reputation. It could lead to an investigation by the SEC and/or
...more
(43)
•••
Breakthorough1
X
Post by
Breakthorough1
on Aug 05, 2023 9:19am
Non-disclosed data
1- COVID (28-Dic-2020: "We are encouraged by the data generated thus far. Results are consistent with the mechanism of action of our DPX delivery platform demonstrated across
...more
(43)
•••
Breakthorough1
X
Post by
Breakthorough1
on Aug 03, 2023 2:28pm
Anyone sending a "Proof of claim"?
"Shareholders and creditors are reminded that in accordance with the Company’s CCAA proceedings, there is an ongoing claims process and they are encouraged to carefully review the information
...more
(43)
•••
Breakthorough1
X
Post by
Breakthorough1
on Aug 03, 2023 12:30pm
November 11 2022
"As a result of our recent reorganization and cost reduction measures, we expect our 2023 average cash burn per quarter to remain consistent with 2022, despite forecasted increases in clinical
...more
(43)
•••
Breakthorough1
X
Post by
Breakthorough1
on Aug 01, 2023 12:27pm
Armistice and Vaxart
"Shareholders of Covid-19 vaccine developer Vaxart Inc. adequately stated insider trading and scheme participation claims against Armistice Capital LLC, a hedge fund linked to Vaxart, a federal
...more
(3)
•••
antigua1987
X
Post by
antigua1987
on Jul 31, 2023 10:16am
Hope for less younger employees of IMV
People like the curr cfo (or whatever title she has) hopefully will be able to shake the absolute slime induced leadership of the more experienced grinders with whom they crossed paths. Even the most
...more
(43)
•••
Breakthorough1
X
Post by
Breakthorough1
on Jul 30, 2023 7:13am
Misleading and forward-looking statements
"The class plaintiffs alleged that statements, including those claiming that production of the Model 3 was “on track,” and “coming in as expected, that there “were no issues,” and that 50
...more
(43)
•••
Breakthorough1
X
Comment by
Breakthorough1
on Jul 29, 2023 4:16pm
RE:Pantginis and Armistice
I mean February 13 (the dsy of the data), sorry: https://markets.businessinsider.com/news/stocks/analysts-offer-insights-on-healthcare-companies-imv-imv-and-siemens-healthineers-ag-othersemhf
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
U.S. DOD Logistics Agency Highlights V.GPH Project to Develop Eco-Friendly Graphite-Based Fire-Fighting Material
Alphamin Announces Record Fy2024 & Q4 2024 Tin Production Fy2025 Production Guidance Exploration Success
Have you held units of a TD mutual fund, other than through a discount broker? Learn more.
BioVaxys Developing DPX to be the Carrier of Choice for mRNA Vaccines, a market projected to grow to USD$48,000,000,000 by 2030*
Eminent's First Drill Hole Hits Significant Gold-Arsenic in Getchell Trend Analogue and Second Hole Drilling Commences